Promising drug cocktail may stall aggressive prostate cancer
NCT ID NCT05171816
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding olaparib to standard abiraterone therapy can slow the growth of metastatic castration-resistant prostate cancer better than abiraterone alone. About 110 men who have not had chemotherapy or newer hormone drugs for this stage of cancer will participate. The main goal is to see how long the cancer stays under control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Beijing, 100034, China
-
Research Site
Beijing, 100050, China
-
Research Site
Beijing, 100142, China
-
Research Site
Beijing, 100191, China
-
Research Site
Beijing, 100730, China
-
Research Site
Chongqing, 400038, China
-
Research Site
Guangzhou, 510180, China
-
Research Site
Guangzhou, 510515, China
-
Research Site
Guizhou, 550002, China
-
Research Site
Henan, 450008, China
-
Research Site
Hubei, 430030, China
-
Research Site
Hunan, 410008, China
-
Research Site
Hunan, 410013, China
-
Research Site
Jilin City, 130012, China
-
Research Site
Jilin City, 130021, China
-
Research Site
Liaoning, 110001, China
-
Research Site
Nanchang, 330006, China
-
Research Site
Nanjing, 2100008, China
-
Research Site
Ningbo, 315000, China
-
Research Site
Shanghai, 200032, China
-
Research Site
Shanghai, 200040, China
-
Research Site
Sichuan, 610041, China
-
Research Site
Sichuan, 610072, China
-
Research Site
Xi'an, 710061, China
-
Research Site
Zhejiang, 310009, China
-
Research Site
Zhejiang, 310014, China